Form 4 holding
EVP & Head of Spec Generics
Mallinckrodt plc
- Security class
- Ordinary Shares
- Shares / value
- 3,631
- Estimated value
- Report date
- 01 Jan 2025
- Price
- $37.50
- Ownership
- Direct
Stephen Andrew Welch - EVP & Head of Spec Generics at Keenova Therapeutics plc
Issuer-level insider activity
- Role
- EVP & Head of Spec Generics
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Stephen Andrew Welch since 14 Aug 2025
Reported holdings for Stephen Andrew Welch in Keenova Therapeutics plc
Form 4 holding
EVP & Head of Spec Generics
Mallinckrodt plc
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 10 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Stephen Andrew Welch in Keenova Therapeutics plc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.